Structures by: Shashidhar M. S.
Total: 93
Hexa-O-benzoyl-myo-inositol
C48H36O12
Chemical Communications (2004) 22 2530-2531
a=13.9840(7)Å b=13.9840(7)Å c=36.504(3)Å
α=90.00° β=90.00° γ=120.00°
Hexa-O-benzoyl-myo-inositol
C48H36O12
Chemical Communications (2004) 22 2530-2531
a=11.931(3)Å b=14.463(4)Å c=14.722(4)Å
α=64.109(4)° β=71.642(5)° γ=67.851(6)°
Hexa-O-benzoyl-myo-inositol
C48H36O12,1.75(CH2Cl2),0.25(H2O)
Chemical Communications (2004) 22 2530-2531
a=13.961(2)Å b=14.214(2)Å c=15.134(2)Å
α=104.827(2)° β=101.516(2)° γ=117.970(2)°
Myo-inositol
C48.5H39BrO13S
Chemical Communications (2001) 10 881
a=26.9267(17)Å b=11.7160(8)Å c=30.874(2)Å
α=90.00° β=105.9980(10)° γ=90.00°
Myo-inositol
C48.25H38.50Cl0.50O13S
Chemical Communications (2001) 10 881
a=26.771(4)Å b=11.608(3)Å c=30.783(6)Å
α=90.00° β=105.176(6)° γ=90.00°
Racemic 2,6-di-O-benzoyl-4-O-methyl-myo-inositol-1,3,5-orthoformate
C22H20O8
Journal of the Chemical Society, Perkin Transactions 2 (2002) 2 358
a=10.442(4)Å b=14.706(6)Å c=14.775(6)Å
α=118.136(6)° β=90.390(7)° γ=90.057(6)°
Racemic 2,6-di-O-benzoyl-4-O-methanesulfonyl-myo-inositol-1,3,5-orthoformate
C22H20O10S
Journal of the Chemical Society, Perkin Transactions 2 (2002) 2 358
a=8.860(3)Å b=11.530(4)Å c=12.079(4)Å
α=109.205(5)° β=105.285(5)° γ=102.015(5)°
4-O-TOSYL 2,6-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=16.4270(17)Å b=6.1377(6)Å c=19.2741(19)Å
α=90.00° β=91.317(2)° γ=90.00°
6-O-TOSYL 2,4-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=6.206(2)Å b=14.602(5)Å c=42.099(13)Å
α=90.00° β=90.00° γ=90.00°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=6.2596(8)Å b=9.8947(12)Å c=17.022(2)Å
α=87.723(2)° β=89.460(2)° γ=76.195(2)°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=9.2713(11)Å b=35.728(4)Å c=6.1772(8)Å
α=90.00° β=90.872(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Cl2O8
CrystEngComm (2008) 10, 3 288
a=6.794(5)Å b=11.545(9)Å c=13.565(10)Å
α=106.843(11)° β=98.733(12)° γ=91.059(12)°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Br2O8
CrystEngComm (2008) 10, 3 288
a=6.825(3)Å b=8.330(4)Å c=18.181(9)Å
α=80.744(9)° β=88.609(9)° γ=83.038(10)°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Cl2O8
CrystEngComm (2008) 10, 3 288
a=6.815(3)Å b=8.325(3)Å c=17.887(7)Å
α=80.140(7)° β=87.493(8)° γ=83.024(8)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH3NO2,0.25(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.401(4)Å b=12.587(4)Å c=13.250(4)Å
α=98.697(5)° β=108.729(5)° γ=117.919(4)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH2Cl2
CrystEngComm (2012) 14, 5 1716
a=13.463(2)Å b=14.451(3)Å c=17.848(3)Å
α=90.00° β=91.363(3)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H4cl2
CrystEngComm (2012) 14, 5 1716
a=13.39(2)Å b=14.35(3)Å c=17.54(3)Å
α=90.00° β=91.55(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.25(CH2Cl2)
CrystEngComm (2012) 14, 5 1716
a=11.499(5)Å b=11.793(5)Å c=12.374(5)Å
α=94.564(7)° β=101.799(7)° γ=105.126(7)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H3N,0.5(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.404(4)Å b=12.492(4)Å c=13.331(4)Å
α=99.188(5)° β=109.620(5)° γ=116.837(4)°
1,2,3,4(6),5-O-PENTA ACETYL 6(4)-O-CAMPHORSULFONYL MYO-INOSITOL
C26H36O14S,0.75(C3H6O)
CrystEngComm (2012) 14, 5 1716
a=13.597(4)Å b=14.351(4)Å c=17.818(5)Å
α=90.00° β=91.466(5)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.75(CHCl3)
CrystEngComm (2012) 14, 5 1716
a=13.857(3)Å b=14.298(3)Å c=17.717(4)Å
α=90.00° β=90.651(4)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Br2O8
CrystEngComm (2008) 10, 3 288
a=6.8481(14)Å b=11.662(2)Å c=13.675(3)Å
α=107.123(4)° β=99.175(4)° γ=90.909(3)°
Tri-O-p-bromo-benzoyl-myo-inositol 1,3,5-orthoformate
C28H19Br3O9
Chemical Communications (2005)
a=57.945(13)Å b=6.0511(13)Å c=15.465(3)Å
α=90.00° β=103.469(4)° γ=90.00°
Tri-O-p-bromo-benzoyl-myo-inositol 1,3,5-orthoformate
C28H19Br3O9
Chemical Communications (2005)
a=10.002(2)Å b=12.126(2)Å c=13.146(3)Å
α=70.536(3)° β=80.100(3)° γ=68.503(3)°
Tri-O-p-chloro-benzoyl-myo-inositol 1,3,5-orthoformate
C28H19Cl3O9
Chemical Communications (2005)
a=10.2740(17)Å b=11.2899(18)Å c=12.717(2)Å
α=75.582(3)° β=86.976(3)° γ=68.503(3)°
4-O-benzyl-myo-inositol-1,3,5-orthoformate
C14H16O6
CrystEngComm (2012) 14, 23 8010
a=10.4043(17)Å b=13.720(2)Å c=10.3515(17)Å
α=90.00° β=118.031(3)° γ=90.00°
4-O-benzyl-myo-inositol-1,3,5-orthoformate
C14H16O6
CrystEngComm (2012) 14, 23 8010
a=10.460(5)Å b=11.536(5)Å c=42.364(19)Å
α=90.00° β=90.00° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Cl2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=12.9731(13)Å b=10.2342(11)Å c=18.0469(19)Å
α=90.00° β=102.585(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Cl2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.047(3)Å b=10.141(3)Å c=18.678(5)Å
α=90.00° β=103.518(4)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate p- xylene solvate
C21H16Cl2O8,0.5(C8H10)
CrystEngComm (2010) 12, 12 4184
a=11.6917(18)Å b=9.6018(15)Å c=21.103(3)Å
α=90.00° β=94.329(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate 1,2- dichloroethane solvate
C21H16Cl2O8,C2H4Cl2
CrystEngComm (2010) 12, 12 4184
a=12.093(2)Å b=9.9108(17)Å c=20.260(3)Å
α=90.00° β=92.433(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetonitrile solvate
C21H16Cl2O8,C2H3N
CrystEngComm (2010) 12, 12 4184
a=12.074(10)Å b=9.861(8)Å c=20.003(16)Å
α=90.00° β=94.894(13)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate benzene solvate
C21H16Cl2O8,0.5(C6H6)2
CrystEngComm (2010) 12, 12 4184
a=32.22(3)Å b=9.584(8)Å c=21.386(19)Å
α=90.00° β=129.72(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,0.06(CH2Cl2)
CrystEngComm (2010) 12, 12 4184
a=12.962(2)Å b=10.1406(17)Å c=18.391(3)Å
α=90.00° β=102.627(3)° γ=90.00°
Hexa-O-toluoyl-myo-inositol
C54H48O12
CrystEngComm (2010) 12, 2 478
a=12.150(8)Å b=14.363(7)Å c=16.451(11)Å
α=99.374(15)° β=106.419(12)° γ=111.167(14)°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Br2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.8141(17)Å b=10.2601(14)Å c=18.756(3)Å
α=90.00° β=102.832(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Br2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.8133(15)Å b=10.2045(12)Å c=18.814(2)Å
α=90.00° β=103.599(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Br2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8524(11)Å b=10.2018(8)Å c=18.5250(15)Å
α=90.00° β=102.8700(10)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate tetrahydrofuran solvate
C21H16Br2O8,C4H8O
CrystEngComm (2010) 12, 12 4184
a=13.181(4)Å b=10.046(3)Å c=18.813(5)Å
α=90.00° β=102.436(4)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Br2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.1856(16)Å b=10.2483(13)Å c=18.966(2)Å
α=90.00° β=104.704(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Br2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=13.0322(15)Å b=10.2499(11)Å c=18.415(2)Å
α=90.00° β=103.579(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate 1,2- dichloroethane solvate
C21H16Br2O8,C2H4Cl2
CrystEngComm (2010) 12, 12 4184
a=12.1687(8)Å b=10.0099(7)Å c=20.3518(14)Å
α=90.00° β=92.6770(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Cl2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.9486(9)Å b=10.2705(7)Å c=18.0529(12)Å
α=90.00° β=101.3980(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Cl2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.751(2)Å b=10.2210(18)Å c=18.520(3)Å
α=90.00° β=103.209(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8921(11)Å b=10.1356(9)Å c=18.0788(16)Å
α=90.00° β=101.5840(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Cl2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.6835(7)Å b=10.0712(5)Å c=18.2980(10)Å
α=90.00° β=103.1000(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate tetrahydrofuran solvate
C21H16Cl2O8,C4H8O
CrystEngComm (2010) 12, 12 4184
a=12.908(3)Å b=10.135(2)Å c=18.299(4)Å
α=90.00° β=101.682(4)° γ=90.00°
4-<i>O</i>-Benzoyl-2-<i>O</i>-phenoxythiocarbonyl-<i>myo</i>-inositol 1,3,5-orthoformate
C21H18O8S
Acta Crystallographica Section C (2016) 72, 11 875-881
a=14.5888(7)Å b=6.0440(3)Å c=21.5364(12)Å
α=90° β=100.216(2)° γ=90°
2-O-benzoyl-myo-inositol-1,3,5-orthoformate
C14H14O7
Acta Crystallographica Section C (1998) 54, 9 1289-1291
a=6.184(2)Å b=17.787(4)Å c=11.746(2)Å
α=90.00° β=91.65(2)° γ=90.00°
Myo inositol
C21H18O8
Acta Crystallographica Section C (2014) 70, 11 1040-1045
a=16.6753(7)Å b=9.8281(5)Å c=22.4931(10)Å
α=90.00° β=90.747(2)° γ=90.00°
Myo inositol cocrystal
C21H18O8,C10H8N2
Acta Crystallographica Section C (2014) 70, 11 1040-1045
a=10.7434(3)Å b=11.4077(4)Å c=11.7341(4)Å
α=82.246(2)° β=65.849(2)° γ=89.549(2)°
4,6-di-O-benzyl-myo-inositol 1,3,5-orthoformate
C21H22O6
Acta Crystallographica Section C (2005) 61, 11 o628-o630
a=9.0511(11)Å b=10.0953(12)Å c=10.6586(13)Å
α=68.849(2)° β=81.453(2)° γ=87.433(2)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthoformate
C18H20O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=8.5756(6)Å b=11.0381(8)Å c=11.2005(8)Å
α=100.4260(10)° β=103.1230(10)° γ=99.6600(10)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthobenzoate
C24H24O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=12.3019(14)Å b=8.2155(10)Å c=23.551(3)Å
α=90.00° β=91.306(2)° γ=90.00°
2,4(6)-di-O-benzoyl-6(4)-O-{[(1S)-7,7-dimethyl-2- oxobicyclo[2.2.1]heptan-1-ylmethyl]sulfonyl}-myo-inositol 1,3,5-orthoacetate
C32H34O11S
Acta Crystallographica Section C (2007) 63, 9 o555-o558
a=11.5241(16)Å b=11.6958(16)Å c=12.453(2)Å
α=80.499(3)° β=62.449(2)° γ=75.937(2)°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=8.8808(6)Å b=9.5502(6)Å c=9.7100(6)Å
α=102.2660(10)° β=101.7330(10)° γ=94.3340(10)°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=13.813(4)Å b=19.279(5)Å c=5.9801(15)Å
α=90.00° β=96.665(4)° γ=90.00°
Racemic epi-inosose
C6H10O6
Acta Crystallographica Section C (2011) 67, 11 o435-o438
a=11.1825(18)Å b=6.9752(12)Å c=8.7930(15)Å
α=90.00° β=90.00° γ=90.00°
4,6-di-<i>O</i>-benzyl-1,3-<i>O</i>-benzylidene-2-<i>O</i>-(4-methoxybenzyl)- <i>myo</i>-5-inosose
C35H34O7
Acta Crystallographica Section C (2012) 68, 5 o183-o187
a=9.492(8)Å b=9.735(8)Å c=16.289(13)Å
α=90.00° β=103.206(12)° γ=90.00°
C36H28O6
C36H28O6
Crystal Growth & Design (2015) 15, 3 1226
a=13.0503(4)Å b=11.4707(3)Å c=18.8224(5)Å
α=90.00° β=91.8080(10)° γ=90.00°
C18H14O3
C18H14O3
Crystal Growth & Design (2015) 15, 3 1226
a=11.8212(9)Å b=7.5692(6)Å c=30.657(2)Å
α=90.00° β=90.00° γ=90.00°
2-O-tosyl-6-O-benzoyl-myo-inositol 1,3,5-orthoformate
C21H20O9S
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=11.626(5)Å b=12.534(5)Å c=13.719(6)Å
α=90° β=95.573(7)° γ=90°
2,6-Di-O-(4-iodobenzoyl)-myo-inositol 1,3,5-orthoformate
C21H16I2O8
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=6.8984(12)Å b=36.230(7)Å c=8.3985(15)Å
α=90° β=96.013(3)° γ=90°
2,6-di-O-(4-toluoyl) myo-inositol 1,3,5-orthoformate
C23H22O8
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=6.8474(15)Å b=11.558(3)Å c=13.858(3)Å
α=108.274(4)° β=98.891(4)° γ=90.870(4)°
C29H31N3O6
C29H31N3O6
Journal of Organic Chemistry (2012) 77, 5801-5807
a=33.130(5)Å b=10.4844(17)Å c=16.523(3)Å
α=90.00° β=111.386(3)° γ=90.00°
C29H31N3O6
C29H31N3O6
Journal of Organic Chemistry (2012) 77, 5801-5807
a=9.3727(19)Å b=10.020(2)Å c=15.193(3)Å
α=102.788(4)° β=104.677(3)° γ=99.305(4)°
C21H23N3O5
C21H23N3O5
Journal of Organic Chemistry (2012) 77, 5801-5807
a=9.929(4)Å b=18.230(6)Å c=21.043(7)Å
α=90.00° β=90.00° γ=90.00°
C14H17N3O5
C14H17N3O5
Journal of Organic Chemistry (2012) 77, 5801-5807
a=10.2239(8)Å b=10.7231(9)Å c=15.4953(13)Å
α=91.7140(10)° β=103.3900(10)° γ=117.7640(10)°
C17H25NO10
C17H25NO10
Journal of Organic Chemistry (2012) 77, 5801-5807
a=15.345(2)Å b=11.1876(18)Å c=12.2187(19)Å
α=90.00° β=103.406(2)° γ=90.00°
C31H31N3O8
C31H31N3O8
Journal of Organic Chemistry (2012) 77, 5801-5807
a=7.4388(5)Å b=26.4633(17)Å c=14.6237(10)Å
α=90.00° β=93.580(3)° γ=90.00°
(+-)-2-benzoyl-4-O-acetyl-myo-inositol-1,3,5-orthoformate
C16H16O8
Journal of the American Chemical Society (1998) 120, 3842-3845
a=8.370(2)Å b=9.473(2)Å c=9.755(3)Å
α=101.29(2)° β=102.87(2)° γ=90.46(2)°
(+-)-2,4-di-O-benzoyl-myo-inositol-1,3,5-orthoformate
C21H18O8
Journal of the American Chemical Society (1998) 120, 3842-3845
a=16.674(5)Å b=9.822(2)Å c=22.533(5)Å
α=90.00° β=90.70(2)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S
Crystal Growth & Design (2005) 5, 3 833
a=14.115(3)Å b=11.592(3)Å c=17.743(4)Å
α=90.00° β=92.529(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.375(CH2Cl2)
Crystal Growth & Design (2005) 5, 3 833
a=30.561(17)Å b=10.925(6)Å c=22.255(12)Å
α=90.00° β=114.922(10)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.75(C6H6)
Crystal Growth & Design (2005) 5, 3 833
a=31.182(4)Å b=11.2219(13)Å c=22.715(3)Å
α=90.00° β=109.948(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.38(C4H8O2)
Crystal Growth & Design (2005) 5, 3 833
a=15.937(4)Å b=11.054(3)Å c=22.206(6)Å
α=90.00° β=108.432(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.5(C6H10O),0.5(C6H12)
Crystal Growth & Design (2005) 5, 3 833
a=31.047(6)Å b=11.2665(18)Å c=22.631(4)Å
α=90.00° β=109.880(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.35(C5H5N),0.38(H2O)
Crystal Growth & Design (2005) 5, 3 833
a=30.623(9)Å b=11.129(4)Å c=22.529(7)Å
α=90.00° β=111.050(5)° γ=90.00°
Myo-inositol 1,3,5-orthobenzoate
C13H14O6
Crystal Growth & Design (2005) 5, 5 1977
a=6.2323(9)Å b=33.014(5)Å c=6.4077(9)Å
α=90.00° β=115.897(2)° γ=90.00°
Myo-inositol 1,3,5-orthobenzoate
C13H14O6
Crystal Growth & Design (2005) 5, 5 1977
a=17.080(4)Å b=6.3196(14)Å c=11.361(3)Å
α=90.00° β=108.087(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.375(CH2Cl2)
Crystal Growth & Design (2006) 6, 6 1485
a=30.561(17)Å b=10.925(6)Å c=22.255(12)Å
α=90.00° β=114.922(10)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1(C4H8O2),0.75(C5H5N)
Crystal Growth & Design (2006) 6, 6 1485
a=30.896(3)Å b=10.9667(11)Å c=22.408(2)Å
α=90.00° β=111.469(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1(C4H8O2),0.25(C4H8O)
Crystal Growth & Design (2006) 6, 6 1485
a=15.966(3)Å b=11.068(3)Å c=22.264(5)Å
α=90.00° β=108.676(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.5(C6H10O),0.5(C6H12)
Crystal Growth & Design (2006) 6, 6 1485
a=31.047(6)Å b=11.2665(18)Å c=22.631(4)Å
α=90.00° β=109.880(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.38(C4H8O2)
Crystal Growth & Design (2006) 6, 6 1485
a=15.937(4)Å b=11.054(3)Å c=22.206(6)Å
α=90.00° β=108.432(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.75(C6H6)
Crystal Growth & Design (2006) 6, 6 1485
a=31.182(4)Å b=11.2219(13)Å c=22.715(3)Å
α=90.00° β=109.948(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.35(C5H5N),0.38(H2O)
Crystal Growth & Design (2006) 6, 6 1485
a=30.623(9)Å b=11.129(4)Å c=22.529(7)Å
α=90.00° β=111.050(5)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.325(C4H8O)
Crystal Growth & Design (2006) 6, 6 1485
a=30.675(6)Å b=11.218(2)Å c=22.323(5)Å
α=90.00° β=113.729(6)° γ=90.00°
Hexa-O-toluoyl-myo-inositol
C54H48O12
CrystEngComm (2010) 12, 2 478
a=12.130(5)Å b=30.223(11)Å c=14.383(5)Å
α=90.00° β=110.068(7)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Br2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.1747(15)Å b=10.1533(12)Å c=19.261(2)Å
α=90.00° β=103.231(2)° γ=90.00°
4-<i>O</i>-Benzoyl-2-<i>O</i>-phenoxycarbonyl-<i>myo</i>-inositol 1,3,5-orthoformate
C21H18O9
Acta Crystallographica Section C (2016) 72, 11 875-881
a=14.7254(3)Å b=5.88190(10)Å c=21.1510(5)Å
α=90° β=99.3210(10)° γ=90°
2-O-(4-toluoyl)myo-inositol 1,3,5-orthoformate
C15H16O7
The Journal of organic chemistry (2018) 83, 7 3952-3959
a=27.213(4)Å b=7.7759(12)Å c=6.5598(10)Å
α=90° β=90° γ=90°
6(4)-O-CAMPHORSULFONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S
Crystal Growth & Design (2006) 6, 6 1485
a=14.115(3)Å b=11.592(3)Å c=17.743(4)Å
α=90.00° β=92.529(4)° γ=90.00°